MSAI · XBRL financial data
MultiSensor AI Holdings financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (MSAI's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue from contracts with customers | — | 7,268 | 5,430 | 7,402 | 5,551 |
| Selling, general and administrative | — | 13,606 | 22,105 | 15,655 | 11,482 |
| Total operating expenses | — | — | 22,921 | 21,429 | 14,413 |
| Operating income (loss) | — | (1,386) | (21,533) | (18,881) | (12,011) |
| Interest income | — | 1,739 | — | — | — |
| Interest expense | — | — | 94 | 63 | — |
| Other income (expense) | — | 48 | 44 | (1,027) | 189 |
| Income tax expense (benefit) | — | 317 | 208 | (465) | (32) |
| Net income (loss) | — | 37 | (22,268) | (21,495) | (11,713) |
| Earnings per share, basic‡ USD per share | — | (100.40) | (142.40) | (42.80) | (12.40) |
| Earnings per share, diluted‡ USD per share | — | (100.40) | (142.40) | (42.80) | (12.40) |
| Weighted average shares, basic‡ thousands of shares | — | 132 | 156 | 503 | 934 |
| Weighted average shares, diluted‡ thousands of shares | — | 132 | 156 | 503 | 934 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-40 stock split (April 2026); filings made before it reported them unadjusted.
Balance sheet
CSVFiscal years (MSAI's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 931 | 222 | 1,155 | 4,358 | 24,365 |
| Accounts receivable | — | 1,508 | 2,440 | 838 | 1,670 |
| Inventory | — | 9,634 | 6,930 | 4,180 | 4,020 |
| Total current assets | 1,316 | 385 | 12,513 | 10,516 | 30,881 |
| Property and equipment, net | — | 2,426 | 3,084 | 3,963 | 4,085 |
| Right-of-use asset | — | 103 | 129 | 134 | 0 |
| Total assets | 118,738 | 119,128 | 16,372 | 15,478 | 35,474 |
| Accounts payable | — | 1,360 | 2,630 | 825 | 291 |
| Accrued liabilities | — | 2,564 | 3,543 | 1,095 | 981 |
| Total current liabilities | — | 6,999 | 10,757 | 3,017 | 2,648 |
| Total liabilities | 200 | 553 | 16,640 | 3,190 | 3,442 |
| Accumulated deficit | (414) | (377) | (33,131) | (54,626) | (66,339) |
| Total stockholders' equity | 1,238 | 120 | (268) | 12,288 | 32,032 |
| Total liabilities and equity | 118,738 | 119,128 | 16,372 | 15,478 | 35,474 |
| Common shares outstanding (cover page)‡ thousands of shares | 376 | 376 | 299 | 824 | 2,012 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-40 stock split (April 2026); filings made before it reported them unadjusted.
Cash flows
CSVFiscal years (MSAI's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Net income (loss) | — | 37 | (22,268) | (21,495) | (11,713) |
| Stock-based compensation | — | 644 | 14,061 | 3,382 | 1,665 |
| Net cash from operating activities | — | (1,016) | (4,551) | (15,567) | (8,020) |
| Net cash from investing activities | — | 307 | (1,512) | (2,667) | (1,607) |
| Proceeds from issuing common stock | — | — | 6,287 | 22,726 | — |
| Net cash from financing activities | — | 2,050 | 6,564 | 21,587 | 29,584 |
| Net change in cash | — | (709) | 501 | 3,353 | 19,957 |
Compare with peers
SIC 3827 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3827 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| MultiSensor AI Holdings | 21,005 | 1,695 | (2,392)* | 2.2M | 8.8 quarters | 10-QJun 30, 2026 |
| Harvard Bioscience | 6,503 | 22,727 | 325* | 4.6M | — | 10-QJun 30, 2026 |
| Optex Systems Holdings | 6,175 | 9,729 | 2,323* | 7.0M | — | 10-QJun 28, 2026 |
| Data I/O | 10,843 | 5,149 | (2,939)* | 10.4M | 3.7 quarters | 10-QJun 30, 2026 |
| Precipio | 3,075 | 7,021 | 660* | 1.8M | — | 10-QJun 30, 2026 |
| ClearSign Technologies | 9,889 | not reported | (1,236)* | 6.8M | 8.0 quarters | 10-QJun 30, 2026 |
| Sypris Solutions | not reported | 30,341 | 1,863* | 23.0M | — | 10-QJul 5, 2026 |
| Focus Universal | 1,600 | 675 | (741)* | 702,745 | 2.2 quarters | 10-QJun 30, 2026 |
| Bionano Genomics | 3,730 | 8,171 | (4,670)* | 11.8M | 2.1 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.